Word

WAYMYO

Status

Pending

Status Code

730

Status Date

Friday, March 8, 2024

Serial Number

97723555

Mark Type

4000

Filing Date

Monday, December 19, 2022

Published for Opposition

Tuesday, October 31, 2023

Trademark Owner History

Classifications

5 Monoclonal antibodies for medical purposes; pharmaceutical preparations, namely, antibodies for the treatment of spinal muscular atrophy (SMA); therapeutic preparations comprising apitegromab, being a monoclonal antibody for the diagnosis, treatment, and prevention of spinal muscular atrophy (SMA), musculoskeletal disorders, neuromuscular diseases and disorders, genetic diseases and disorders, and neurological diseases and disorders; therapeutic agents and pharmaceutical preparations for the diagnosis, treatment, and prevention of musculoskeletal disorders, neuromuscular diseases and disorders, genetic diseases and disorders, and neurological diseases and disorders

Trademark Events

Mar 9, 2024

Notice Of Approval Of Extension Request E-Mailed

Mar 8, 2024

Sou Extension 1 Granted

Mar 8, 2024

Sou Extension 1 Filed

Mar 8, 2024

Sou Teas Extension Received

Dec 26, 2023

Noa E-Mailed - Sou Required From Applicant

Oct 31, 2023

Official Gazette Publication Confirmation E-Mailed

Oct 31, 2023

Published For Opposition

Oct 11, 2023

Notification Of Notice Of Publication E-Mailed

Sep 25, 2023

Approved For Pub - Principal Register

Sep 25, 2023

Examiner's Amendment Entered

Sep 25, 2023

Notification Of Examiners Amendment E-Mailed

Sep 25, 2023

Examiners Amendment E-Mailed

Sep 25, 2023

Examiners Amendment -Written

Sep 20, 2023

Assigned To Examiner

Dec 22, 2022

New Application Office Supplied Data Entered

Dec 22, 2022

New Application Entered